174 related articles for article (PubMed ID: 2981690)
21. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
22. Thymus-derived macrophages in long-term culture: release of IL-1, stimulation of MLR and expression of tumoricidal activity.
Gallily R; Zeira M; Stain I
Immunology; 1985 May; 55(1):165-72. PubMed ID: 3158594
[TBL] [Abstract][Full Text] [Related]
23. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
Fischer A; Le Deist F; Durandy A; Griscelli C
J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
[TBL] [Abstract][Full Text] [Related]
24. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
25. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
Walker C; Kristensen F; Bettens F; deWeck AL
J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 regulation of tumoristatic factor production by macrophage-like P388D1 cells.
Young MR; Simmermaker JA
J Natl Cancer Inst; 1984 Oct; 73(4):959-62. PubMed ID: 6592390
[TBL] [Abstract][Full Text] [Related]
27. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
28. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.
Bitterman PB; Wewers MD; Rennard SI; Adelberg S; Crystal RG
J Clin Invest; 1986 Mar; 77(3):700-8. PubMed ID: 3081573
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 release triggered by phagocytosis of latex particles. A distinct association with prostaglandin synthase isozymes in bone marrow macrophages.
Shibata Y
J Immunol; 1995 Mar; 154(6):2878-87. PubMed ID: 7876556
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages.
Sitrin RG; Kaltreider HB; Goldyne ME
J Immunol; 1984 Feb; 132(2):867-71. PubMed ID: 6581228
[TBL] [Abstract][Full Text] [Related]
31. Bone resorption activity of particulate-stimulated macrophages.
Glant TT; Jacobs JJ; Molnár G; Shanbhag AS; Valyon M; Galante JO
J Bone Miner Res; 1993 Sep; 8(9):1071-9. PubMed ID: 8237476
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.
Roper RL; Phipps RP
J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389
[TBL] [Abstract][Full Text] [Related]
33. Regulation of human immunoglobulin production in vitro by prostaglandin E2.
Staite ND; Panayi GS
Clin Exp Immunol; 1982 Jul; 49(1):115-22. PubMed ID: 6957277
[TBL] [Abstract][Full Text] [Related]
34. Tumor-induced variations in a high molecular weight inhibitory monokine.
Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
[TBL] [Abstract][Full Text] [Related]
35. Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
Monick M; Glazier J; Hunninghake GW
Am Rev Respir Dis; 1987 Jan; 135(1):72-7. PubMed ID: 3492161
[TBL] [Abstract][Full Text] [Related]
36. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E.
Beharka AA; Wu D; Han SN; Meydani SN
Mech Ageing Dev; 1997 Feb; 93(1-3):59-77. PubMed ID: 9089571
[TBL] [Abstract][Full Text] [Related]
37. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
Alleva DG; Burger CJ; Elgert KD
Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
[TBL] [Abstract][Full Text] [Related]
38. Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.
Jelinek DF; Thompson PA; Lipsky PE
J Clin Invest; 1985 Apr; 75(4):1339-49. PubMed ID: 3872889
[TBL] [Abstract][Full Text] [Related]
39. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
40. Production of prostaglandin E2 and interleukin 1 by mouse peritoneal macrophages stimulated with beta-1,3-D-glucan derivatized plastic beads.
Rasmussen LT; Lipsky PE; Seljelid R
Scand J Immunol; 1987 Dec; 26(6):731-6. PubMed ID: 3501158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
